The improvement in endothelial function could be attributed to several mechanisms: PCSK9 inhibitors' ability to lower LDL-C levels can mitigate endothelial cell damage caused by elevated LDL-C, thereby preventing endothelial dysfunction (46). Here, PCSK9 is linked to endothelial dysfunction.